REFERENCES
- Young J L, Ries L G, Silverberg E, et al. Cancer incidence, survival and mortality for children younger than age 15 years. Cancer. 1986; 58: 598, [PUBMED], [INFOTRIEVE]
- Ries L A. Cancer: Rates and Risks, A Harras, B K Edwards, W J Blot, et al. National Cancer Institute, Bethesda, MD 1996; 9–54
- Yvone K, Levin V A. Advances in gene therapy and immunotherapy for brain tumors. Curr Opin Neurol. 2003; 16: 665–670, [CSA]
- Strother D R, Pollack I F, Fisher P G, . Tumors of the central nervous system. Principles and Practice of Pediatric Oncologyed 4, P A Pizzo, D G Poplack, et al. Lipincott Williams & Williams, Philadelphia 2002; 760–762
- Warren K E, Frank J A, Black J L, et al. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors. J Clin Oncol. 2000; 18: 1020, [PUBMED], [INFOTRIEVE]
- Hustinx R, Alavi A. SPECT and PET imaging of brain tumors. Neuroimaging Clin N Am 1999; 12: 341–348
- Broggi G, Franzini A, Migliavacca F, et al. Stereotactic biopsy of deep brain tumors in infancy and childhood. Childs Brain 1983; 10: 92–98, [PUBMED], [INFOTRIEVE]
- Martin A J, Hall W A, Liu H, et al. Brain tumor resection: intraoperative monitoring with high-field strength MR imaging initial results. Radiology 2000; 215: 221–228, [PUBMED], [INFOTRIEVE], [CSA]
- Wellons J C, Tubbs R S, Banks J T, et al. Long term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas. Neurosurgery 2002; 51: 63–67, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Barrer S J, Schut L, Sutton L N, et al. Re-operation for recurrent brain tumors in children. Childs Brain 1984; 11: 375–386, [PUBMED], [INFOTRIEVE]
- Foreman N K, Love S, Gill S S, et al. Second look surgery for incompletely resected fourth ventricle ependymomas: technical case report. Neurosurgery 1997; 40: 856–860, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Leber K A. Dose–response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88: 43–50, [PUBMED], [INFOTRIEVE]
- Hodgson D C, Goumnervora L C, Loeffler J S, et al. Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 2001; 50: 929–935, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Murthy V, Jalali R, Sarin R, et al. Stereotactic conformal radiotherapy (SCRT) for posterior fossa tumours: a modelling study for potential improvement in therapeutic ratio. Radiother Oncol 2003; 67: 191–198, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perks J, Jalali R, Cosgrove V, et al. Optimisation of stereotactically guided conformal treatment planning of sellar and parasellar tumors based on normal brain dose volume histograms. Int J Radiat Oncol Biol Phys 1999; 45: 415–425, [CSA], [CROSSREF]
- Freeman C R, Patrocinio H, Farmer J P. Highly conformal radiotherapy for craniopharyngioma (potentially) throwing the baby out with the bathwater. Med Pediatr Oncol 2003; 40: 340–341, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Merchant T, Zhu Y, Thompson S, et al. Preliminary results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytomas and ependymomas. Int J Radiat Oncol Biol Phys 2002; 5: 325–332, [CROSSREF]
- Schaake-Konig C, Vanden Bagaret C V, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. New Engl J Med 1992; 326: 524–530
- Jaeckle K A, Hess K R, Gleason M J, et al. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant gliomas: a North American Brain Tumor Consortium Study. J Clin Oncol. 2003; 21: 2305–2311, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Taylor R E, Bailey C C, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Pediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003; 21: 1581–1591, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Packer R J, Goldwein J, Nicholson H S, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 1999; 17: 2127–2136, [PUBMED], [INFOTRIEVE]
- Freidman H S, Keir S, Pegg A E, et al. O6-Benzylguanine mediated enhancement of chemotherapy. Mol Cancer Ther. 2002; 1: 943–948, [CSA]
- Grovas A C, Boyett J M, Lindsley K, et al. Regimen related toxicity of myeloablative chemotherapy with BCNU, thiotepa and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children' Cancer Group. Med Pediatr Oncol 1999; 33: 83–87, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mason W P, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998; 16: 210–221, [PUBMED], [INFOTRIEVE]
- Emerich D F, Dean R L, Osborn C, et al. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood–brain barrier: from concept to clinical evaluation. Clin Pharmacokinet 2001; 40: 105–123, [PUBMED], [INFOTRIEVE], [CSA]
- Warren K E, Patel M C, Aikin A A, et al. Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. Cancer Chemother Pharmacol 2001; 48: 275–282, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blaney S M, Heideman R, Berg S, et al. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003; 21: 143–147, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Slav I, Schuller E, Czech T, et al. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination. J Neurooncol 1998; 38: 213–218, [CSA], [CROSSREF]
- Slav I, Schuller E, Falger J, et al. Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors. J Neurooncol. 2003; 64: 239–247, [CSA], [CROSSREF]
- Mukherjee P, Das S K. Antiproliferative action of retinoic acid in cultured human brain tumor cells G1-AS-14S. Cancer Lett 1990; 52: 83–89, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shawver L K, Slamon D, Ullrich A. Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 2002; 1: 117–123, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Traxler P, Bold G, Buchdunger E, et al. Tyrosine kinase inhibitors: from rational design to clinical trials. Med Res Rev 2001; 21: 499–512, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Khatua S, Peterson K M, Brown K M, et al. Overexpression of the EGFR/FKBP12/HIF2α pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 2003; 63: 1865–1870, [PUBMED], [INFOTRIEVE]
- Riva P, Francesschi G, Arista A, et al. Local application of radiolabelled monoclonal antibodies in the treatment of high grade malignant gliomas: a six year clinical experience. Cancer 1997; 80: 2733–2742, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hussain S R, Puri R K. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. J Neurooncol 2003; 65: 37–48, [CSA], [CROSSREF]
- Rustamzadeh E, Low W C, Vallera D A, et al. Immunotoxin therapy for CNS tumor. J Neuro-Oncol 2003; 64: 101–116, [CSA], [CROSSREF]
- Yamanaka R, Abe T, Yajima N, et al. Vaccination of recurrent glioma patients with tumor lysate-pulsed dendritic cells elicits immune responses: result of a clinical phase I/II trial. Br J Cancer 2003; 89: 1172–1179, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yates A J, Stephens R E, Elder P J, et al. Effects of interferons and gangliosides on growth on cultured human glioma and fetal brain cells. Cancer Res 1985; 45: 1033–1039, [PUBMED], [INFOTRIEVE]
- Pollack I F, Okada H, Chambers W H. Exploitation of immune mechanism in the treatment of central nervous system cancer. Sem Pediatr Neural 2000; 7: 131–143
- Mahaley M S, Dropcho E J, Bertsch L, et al. Systemic beta-interferon therapy for recurrent gliomas, a brief report. J Neurosurg 1989; 71: 639–641, [PUBMED], [INFOTRIEVE]
- Culver K W, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of expiremental brain tumors. Science 1992; 256: 1550–1552, [PUBMED], [INFOTRIEVE]
- Sandmair A M, Loimas S, Puranen P, et al. Thymidine kinase gene therapy for human malignant glioma, using replication deficient retroviruses or adenoviruses. Hum Gene Ther 2000; 11: 2197–2205, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Packer R J, Raffel C, Villablanca J G, et al. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector, producer cells followed by intravenous ganciclovir administration. J Neurosurg 2000; 92: 249–254, [PUBMED], [INFOTRIEVE]
- Lang F F, Bruner J M, Fuller G N, et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003; 21: 2508–2518, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hamel W, Westphal M. Gene therapy of gliomas. Acta Neurochir Suppl 2003; 88: 125–135, [PUBMED], [INFOTRIEVE], [CSA]